ArticleEJNMMI research2024

Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer.

Neree Payan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.